Streetbeat News

Stock Prices

LYB

Citigroup analyst Patrick Cunningham downgraded LyondellBasell Industries (NYSE:LYB) from Buy to Neutral and reduced the price target from $105 to $98.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:17 pm

INSP

Wells Fargo analyst Larry Biegelsen downgraded Inspire Medical Systems (INSP) from Overweight to Equal-Weight and set a price target of $187.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:10 pm

NFLX

Netflix, Inc. (NASDAQ:NFLX) released its first Engagement Report, revealing viewer preferences and highlighting 'The Night Agent' as the most-watched program with over 812 million hours viewed. The report covers 18,000 titles and nearly 100 billion hours of content watched. Non-English content accounted for 30% of viewership. Netflix also noted the value of older, licensed titles and ended its DVD rental business. NFLX shares saw a slight premarket increase to $463.20.

Portfolio Pulse from Nabaparna Bhattacharya

December 13, 2023 | 12:10 pm

VBNK

VersaBank (NASDAQ:VBNK) reported Q4 earnings with an EPS of $0.35, beating estimates by 25% against the expected $0.28. Revenue increased by $3.51 million compared to the same period last year. Despite missing EPS estimates last quarter by $0.03, the share price rose by 4.27% the following day.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:10 pm

CGNT

Cognyte Software (NASDAQ:CGNT) reported Q3 earnings with an EPS of $0.34, significantly beating the estimate of $0.01. Revenue increased by $7.90 million compared to the same period last year. Despite beating EPS estimates last quarter, CGNT's share price dropped by 4.36% the following day. Historical earnings and revenue figures show mixed performance over the past four quarters.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 12:10 pm

CHD

Citigroup analyst Filippo Falorni has downgraded Church & Dwight Co (CHD) from Neutral to Sell and set a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:08 pm

RCM

JP Morgan analyst Anne Samuel downgraded R1 RCM (NASDAQ:RCM) from Overweight to Neutral and reduced the price target from $20 to $11, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:07 pm

EYPT

PLNT

PLSE

RHP

The article reports on notable insider purchases of shares in four companies, suggesting confidence in their prospects. Ryman Hospitality Properties' Colin V Reed acquired shares worth $2.04 million. EyePoint Pharmaceuticals saw a $10 million purchase by Cormorant Global Healthcare Master Fund LP. Pulse Biosciences' Robert Duggan bought shares for $1.11 million. Planet Fitness' Interim CEO Craig Benson purchased shares amounting to $681,464. Recent company developments are also mentioned, such as quarterly sales, public offerings, regulatory approvals, and financial results.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:04 pm

ABM

ABM Industries Inc. forecasts its FY24 earnings per share (EPS) to be in the range of $3.20 to $3.40, which compares to the estimated $3.28.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:03 pm

REVG

REV Group (NYSE:REVG) reported Q4 earnings of $0.53 per share, surpassing the consensus estimate of $0.34 by 55.88% and marking an 89.29% increase from the previous year. Sales reached $693.30M, exceeding estimates of $666.13M by 4.08% and showing an 11.18% increase from the prior year.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:02 pm